Compass Therapeutics Inc
(CMPX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2005 | 12-2004 | 09-2004 | 06-2004 | 03-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,270 | 1,250 | 220 | 3,050 | 3,280 |
| Depreciation Amortization | 1,170 | 940 | 350 | 1,810 | 1,300 |
| Other Working Capital | -5,540 | -4,690 | -1,260 | -5,760 | -3,060 |
| Other Operating Activity | 150 | 10 | 20 | -1,100 | 0 |
| Operating Cash Flow | $-2,950 | $-2,490 | $-670 | $-2,000 | $1,520 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,720 | -1,320 | -230 | -1,600 | -760 |
| Net Acquisitions | 0 | 0 | 0 | -3,420 | 0 |
| Other Investing Activity | 0 | -10 | -20 | 100 | 40 |
| Investing Cash Flow | $-1,720 | $-1,330 | $-250 | $-4,920 | $-720 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 4,310 | 3,520 | 1,460 | 5,020 | 970 |
| Financing Cash Flow | $4,310 | $3,520 | $1,460 | $5,020 | $970 |
| Exchange Rate Effect | -350 | -160 | 20 | 40 | -230 |
| Beginning Cash Position | 3,190 | 3,190 | 3,190 | 5,050 | 2,080 |
| End Cash Position | 2,480 | 2,720 | 3,750 | 3,190 | 3,620 |
| Net Cash Flow | $-710 | $-470 | $550 | $-1,850 | $1,530 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,950 | -2,490 | -670 | -2,000 | 1,520 |
| Free Cash Flow | -2,950 | -2,490 | -670 | -2,000 | 1,520 |